HIV (Human Immunodeficiency Virus) Clinical Trials

13 recruitingLast updated: June 18, 2026

There are 13 actively recruiting hiv (human immunodeficiency virus) clinical trials across 10 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include San Francisco, California, United States, Birmingham, Alabama, United States, Cairo, Egypt. Updated daily from ClinicalTrials.gov.


HIV (Human Immunodeficiency Virus) Trials at a Glance

13 actively recruiting trials for hiv (human immunodeficiency virus) are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in San Francisco, Birmingham, and Cairo. Lead sponsors running hiv (human immunodeficiency virus) studies include University of California, San Francisco, Brown University, and Barcelona Institute for Global Health.

Browse hiv (human immunodeficiency virus) trials by phase

Treatments under study

About HIV (Human Immunodeficiency Virus) Clinical Trials

Looking for clinical trials for HIV (Human Immunodeficiency Virus)? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIV (Human Immunodeficiency Virus) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIV (Human Immunodeficiency Virus) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2

Boosting Olfactory and Sensory Training Study (BOOST)

HIV (Human Immunodeficiency Virus)
University of Alabama at Birmingham80 enrolled1 locationNCT07221123
Recruiting
Phase 2

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

HIV (Human Immunodeficiency Virus)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Naga P. Chalasani120 enrolled10 locationsNCT07143968
Recruiting
Not Applicable

Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care

HIV (Human Immunodeficiency Virus)StigmaContinuum of Care
University of California, Los Angeles80 enrolled1 locationNCT07495059
Recruiting

Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment

HIV (Human Immunodeficiency Virus)
University Hospital, Toulouse30 enrolled1 locationNCT07062614
Recruiting
Not Applicable

Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release

HIV (Human Immunodeficiency Virus)
University of California, San Francisco33 enrolled1 locationNCT07115901
Recruiting
Not Applicable

Improving Access to HIV Testing for Children in Uganda

HIV (Human Immunodeficiency Virus)
University of California, San Francisco400 enrolled1 locationNCT07236905
Recruiting
Phase 2

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Metabolic SyndromeObesity, OverweightHIV (Human Immunodeficiency Virus)
Abdelrahman Mahmoud66 enrolled1 locationNCT07336797
Recruiting

Questioning the Epidemiology of Asymptomatic TB

TuberculosisHIV (Human Immunodeficiency Virus)HIV+1 more
Barcelona Institute for Global Health6,770 enrolled1 locationNCT07312266
Recruiting
Phase 1

The DART DELIVER-02 Study

HIV (Human Immunodeficiency Virus)
University of North Carolina, Chapel Hill24 enrolled3 locationsNCT07217379
Recruiting
Not Applicable

Integrating Project YES! With WHO-Endorsed Mental Health Approaches Among Youth Living With HIV

AnxietyHIV (Human Immunodeficiency Virus)Mental Health+2 more
Johns Hopkins Bloomberg School of Public Health400 enrolled1 locationNCT07221201
Recruiting
Phase 4

HIV Prevention With PrEP Among People on Opioid Replacement Therapy

HIV (Human Immunodeficiency Virus)
Cara Spence350 enrolled6 locationsNCT07160075
Recruiting
Phase 3

DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity

ObesityHIV (Human Immunodeficiency Virus)Overweight and/or Obesity
José Antonio Mata Marín306 enrolled1 locationNCT07075146
Recruiting
Not Applicable

Pre-exposure Prophylaxis (PrEP) for Health

HIV (Human Immunodeficiency Virus)Substance Dependence
Brown University200 enrolled2 locationsNCT04430257